mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for FABP2
Gene summary
Basic gene Info.Gene symbolFABP2
Gene namefatty acid binding protein 2, intestinal
SynonymsFABPI|I-FABP
CytomapUCSC genome browser: 4q28-q31
Type of geneprotein-coding
RefGenesNM_000134.3,
Descriptionfatty acid-binding protein 2fatty acid-binding protein, intestinalintestinal-type fatty acid-binding protein
Modification date20141207
dbXrefs MIM : 134640
HGNC : HGNC
Ensembl : ENSG00000145384
HPRD : 00611
Vega : OTTHUMG00000132972
ProteinUniProt: P12104
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_FABP2
BioGPS: 2169
PathwayNCI Pathway Interaction Database: FABP2
KEGG: FABP2
REACTOME: FABP2
Pathway Commons: FABP2
ContextiHOP: FABP2
ligand binding site mutation search in PubMed: FABP2
UCL Cancer Institute: FABP2
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for FABP2

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
D75,T77G76ESKCM2
Y15D16EBRCA1
L103E102KCOAD1
L103N104DCOAD1
L103N104ICOAD1
L103N104KOV1
M19M19ISKCM1
L103E102KSKCM1
F56R57QSTAD1
L79R80KSTAD1
Y118V119AUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for FABP2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
Y118V119A-1.9036613
L79R80K-1.0731011
Y15D16E-0.94562151
L103E102K-0.86985325
F56R57Q-0.78370392
L103N104D-0.70155449
M19M19I-0.67223231
L103N104K-0.54098764
L103N104I-0.13939208
D75G76E-0.10616453
T77G76E-0.10616453
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for FABP2 from PDB
PDB IDPDB titlePDB structure
1KZWSolution structure of Human Intestinal Fatty acid binding protein

Top
Differential gene expression and gene-gene network for FABP2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of FABP2 and the right PPI network was created from samples without mutations in the LBS of FABP2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for FABP2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for FABP2
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
ApprovedDB01050IbuprofenSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of FABP2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of FABP2
Multiple alignments for P12104 in multiple species
LBSAA sequence# speciesSpecies
A32VKRKLAAHDNL2Homo sapiens, Bos taurus
A32MKRKLGAHDNL1Mus musculus
A32VKRKLGAHDNL1Rattus norvegicus
A74FNYNLADGTEL1Homo sapiens
A74FPYSLADGTEL1Mus musculus
A74FAYSLADGTEL1Rattus norvegicus
A74FNYSLADGTEL1Bos taurus
D75NYNLADGTELR1Homo sapiens
D75PYSLADGTELT1Mus musculus
D75AYSLADGTELT1Rattus norvegicus
D75NYSLADGTELS1Bos taurus
E52KFTVKESSNFR2Mus musculus, Rattus norvegicus
E52KFTVKESSAFR1Homo sapiens
E52KFTVKESSTFR1Bos taurus
F18ENYEKFMEKMG3Mus musculus, Rattus norvegicus, Bos taurus
F18ENYDKFMEKMG1Homo sapiens
F56KESSNFRNIDV2Mus musculus, Rattus norvegicus
F56KESSAFRNIEV1Homo sapiens
F56KESSTFRSIEI1Bos taurus
F63NIEVVFELGVT1Homo sapiens
F63NIDVVFELGVN1Mus musculus
F63NIDVVFELGVD1Rattus norvegicus
F63SIEIIFELGVT1Bos taurus
F69ELGVTFNYNLA1Homo sapiens
F69ELGVNFPYSLA1Mus musculus
F69ELGVDFAYSLA1Rattus norvegicus
F69ELGVTFNYSLA1Bos taurus
F94KLIGKFKRTDN1Homo sapiens
F94KLIGKFTRVDN1Mus musculus
F94KLVGKFKRVDN1Rattus norvegicus
F94KLVGKFKRLDN1Bos taurus
K28GVNIVKRKLAA1Homo sapiens
K28GINVMKRKLGA1Mus musculus
K28GINVVKRKLGA1Rattus norvegicus
K28GINVVKRKLAA1Bos taurus
L103DNGKELIAVRE2Mus musculus, Rattus norvegicus
L103DNGNELNTVRE1Homo sapiens
L103DNGNALNTVRE1Bos taurus
L73TFNYNLADGTE1Homo sapiens
L73NFPYSLADGTE1Mus musculus
L73DFAYSLADGTE1Rattus norvegicus
L73TFNYSLADGTE1Bos taurus
L79ADGTELRGTWS1Homo sapiens
L79ADGTELTGAWT1Mus musculus
L79ADGTELTGTWT1Rattus norvegicus
L79ADGTELSGAWA1Bos taurus
M19NYEKFMEKMGI3Mus musculus, Rattus norvegicus, Bos taurus
M19NYDKFMEKMGV1Homo sapiens
M22KFMEKMGINVV2Rattus norvegicus, Bos taurus
M22KFMEKMGVNIV1Homo sapiens
M22KFMEKMGINVM1Mus musculus
Q116GNELIQTYTYE2Mus musculus, Rattus norvegicus
Q116GDELVQTYVYE1Homo sapiens
Q116GGEMVQTYTYE1Bos taurus
R107ELNTVREIIGD1Homo sapiens
R107ELIAVREVSGN1Mus musculus
R107ELIAVREISGN1Rattus norvegicus
R107ALNTVREIIGG1Bos taurus
R127GVEAKRIFKKE2Rattus norvegicus, Bos taurus
R127GVEAKRIFKKD1Homo sapiens
R127GVEAKRFFKKE1Mus musculus
T77NLADGTELRGT1Homo sapiens
T77SLADGTELTGA1Mus musculus
T77SLADGTELTGT1Rattus norvegicus
T77SLADGTELSGA1Bos taurus
V24MEKMGINVVKR2Rattus norvegicus, Bos taurus
V24MEKMGVNIVKR1Homo sapiens
V24MEKMGINVMKR1Mus musculus
V50GNKFTVKESSN2Mus musculus, Rattus norvegicus
V50GNKFTVKESSA1Homo sapiens
V50GNKFTVKESST1Bos taurus
V61FRNIDVVFELG2Mus musculus, Rattus norvegicus
V61FRNIEVVFELG1Homo sapiens
V61FRSIEIIFELG1Bos taurus
W83ELRGTWSLEGN1Homo sapiens
W83ELTGAWTIEGN1Mus musculus
W83ELTGTWTMEGN1Rattus norvegicus
W83ELSGAWALEGD1Bos taurus
Y118ELIQTYTYEGV2Mus musculus, Rattus norvegicus
Y118ELVQTYVYEGV1Homo sapiens
Y118EMVQTYTYEGV1Bos taurus
Y15DRNENYEKFME3Mus musculus, Rattus norvegicus, Bos taurus
Y15DRSENYDKFME1Homo sapiens
Y71GVTFNYNLADG1Homo sapiens
Y71GVNFPYSLADG1Mus musculus
Y71GVDFAYSLADG1Rattus norvegicus
Y71GVTFNYSLADG1Bos taurus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas